Natixis Publication of Suppl.Prospcts

RNS Number : 7122F

Natixis

26 September 2024

 

The following base prospectus supplement has been approved by the UK Financial Conduct Authority and is available for viewing:

 

First supplement (the "First Supplement") to the base prospectus dated 19 July 2024 (the "Base Prospectus") relating to the £1,000,000,000 UK Debt Issuance Programme of NATIXIS and Natixis Structured Issuance S.A..

 

To view the full document, please paste the following URL into the address of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/7122F_1-2024-9-25.pdf

 

For further information, please contact:

 

Name:  Régis PARRIMOND

Email:   [e-mail]

Tel:        [phone]

 

Name:  Monia MECHROUB

Email:   [e-mail]

Tel:        [phone]

 

Name:  Charlotte LETELLIER

Email:   [e-mail]

Tel:         [phone]

 

Name:  Matthieu CARMENT

Email:   [e-mail]

Tel:       [phone]

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and the First Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus and the First Supplement you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. By accessing this document, you will be deemed to certify that you are located outside the United States and are not accessing the Base Prospectus from a location inside the United States.

 

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

PSPDBGDCSUDDGSU